Salmeterol use and risk of hospitalization among emergency department patients with acute asthma. Academic Article uri icon

Overview

abstract

  • BACKGROUND: The safety of inhaled long-acting beta2-agonists (LABAs) in the treatment of chronic asthma remains controversial and has not been evaluated in emergency department (ED) patients with acute asthma. OBJECTIVE: To determine whether ED patients undergoing long-term LABA therapy would have increased risk of asthma-related hospitalization compared with those not undergoing LABA therapy and whether concurrent long-term inhaled corticosteroid (ICS) therapy would mitigate this risk. METHODS: Prospective cohort study of patients aged 12 to 54 years with acute asthma in 115 EDs. Four patient groups were created based on their asthma regimen: no ICS or salmeterol (group A), salmeterol monotherapy (group B), ICS monotherapy (group C), and combination ICS and salmeterol (group D). RESULTS: Of the 2,236 included patients, group A had 1,221 patients (55%), group B had 48 patients (2%), group C had 787 patients (35%), and group D had 180 patients (8%); 489 patients (22%) required hospitalization. In a multivariable model controlling for 20 factors and using group A as the reference, group B had an increased risk of hospitalization (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.0-4.9), whereas groups C (OR, 1.1; 95% CI, 0.8-1.5) and D (OR, 1.2; 95% CI, 0.8-1.9) did not. CONCLUSION: Among ED patients with acute asthma, those undergoing salmeterol monotherapy had an increased risk of hospitalization; however, this risk was not seen among patients undergoing combination ICS-salmeterol therapy. Our findings provide data from a unique ED population on clinical response to acute asthma treatment among patients undergoing long-term LABA therapy.

publication date

  • June 1, 2010

Research

keywords

  • Adrenergic beta-Agonists
  • Albuterol
  • Asthma
  • Hospitalization

Identity

PubMed Central ID

  • PMC2945216

Scopus Document Identifier

  • 77953163429

Digital Object Identifier (DOI)

  • 10.1016/j.anai.2010.04.014

PubMed ID

  • 20568379

Additional Document Info

volume

  • 104

issue

  • 6